2020 Drug Design and Delivery Symposium
We are planning a diverse set of broadcasts for this year’s symposium and will feature the most innovative and revolutionary ideas in drug design and delivery. The details for upcoming broadcasts will be posted as they are finalized.
Mar 19 |
Passive Permeability: An Important Mechanism for Drug Absorption Li Di - Pfizer Faraj Atassi - AstraZeneca |
Apr 15 | COVID-19: A Groundwork for Therapeutic Agents and Vaccines Qiongqiong Angela Zhou - CAS Dennis Liotta - Emory Institute for Drug Development |
Apr 30 |
How Drugs Really Get Into Cells: Why Passive Bilayer Diffusion is a Myth Douglas Kell - University of Liverpool Mike Sinz - Bristol-Myers Squibb |
May 28 |
mRNA Technology for Infectious Diseases: Therapeutic Applications and Vaccine Development Jim Thompson - Moderna, Inc. Venkat Krishnamurthy - Astrazeneca |
Jun 25 |
Enabling Technologies for Revealing Druggable Paths in RNA Biology Amanda Garner - University of Michigan Matt Disney - The Scripps Research Institute |
Jul 30 |
Nature’s Dirty Little Secret: The Diverted Total Syntheses of Rhizosphere Natural Products as Targeted Antibacterial Agents |
Sep 23 |
Mitragyna Speciosa: What Science is Telling Us about Kratom Christopher McCurdy - College of Pharmacy, University of Florida Amy Newman - NIDA-Intramural Research Program, National Institutes of Health |
Oct 29 |
Mitigating Drug-Induced Liver Injury: Assessing Mitochondrial Toxicity and Reactive Metabolism Yvonne Will - Janssen Pharmaceutical Kevin Coe - Janssen Pharmaceutical Kaushik Mitra - Janssen Research & Development |
Nov 19 |
Mitigating Drug-Induced Liver Injury 2: Assessing Transporter Liabilities and Bioactivation Transcriptomics Michael Hafey - Merck Jim Monroe - Merck Wen Kang - Merck Kaushik Mitra - Janssen Research & Development |

MEET THE ORGANIZERS
Annette Bak
AstraZeneca
Lorraine Clark
ACS Publications
Patrice L. Jackson-Ayotunde
Univ. of Maryland Eastern Shore
Anirban Mahapatra
ACS Publications
Nicholas Meanwell
Bristol-Myers Squibb
John Morrison
The Janssen Pharmaceutical Companies of Johnson & Johnson
Nurulain Zaveri
Astraea Therapeutics